Commentary [ Research Highlights(To miR or Not to miR: That is the Question in ALS Disease ]

E-ISSN： 1996-3181|10|6|648-649

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.6, 2011-09, pp. : 648-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commentary (Research Highlights: Targeted Inhibition of miR-155 Promotes Post-Stroke Neovascularization and Functional Recovery)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 4, 2016-05 ,pp. : 372-374

Bentham Science Publishers

Access to resources Recommend Favorite

Serum miR‐146a, miR‐155, and miR‐210 as potential markers of Graves’ disease

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of miR-145 in microvasculature

By Ji Li-ya Jiang De-qian Dong Ni-ni

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 6, 2013-06 ,pp. : 387-391

Govi-Verlag

Access to resources Recommend Favorite

Commentary: (Research Highlights: “MiRNAcles” in Brain)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 6, 2013-09 ,pp. : 717-718

Bentham Science Publishers

Access to resources Recommend Favorite

miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 503-508

Bentham Science Publishers

Access to resources Recommend Favorite